✅ MEI Pharma confirms the adoption of Litecoin as an official reserve

MEI Pharma has officially announced an investment of $100 million in Litecoin to become the first public company to adopt it as a reserve asset. The deal includes the addition of the Litecoin innovator to the board of directors and is scheduled to be completed on July 22, 2025.